Astex Pharmaceuticals (ASTX) Falls After FDA Briefing Documents
Tweet
Share
E-mailGet Alerts ASTX Hot Sheet
Join SI Premium – FREE
Astex Pharmaceuticals, Inc. (Nasdaq: ASTX) is seeing pressure as FDA briefing documents posted. Link
Comments look cautious.
Shares last traded at $2.31, down 17%.
Comments look cautious.
Shares last traded at $2.31, down 17%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic hires Google chip veteran as it pushed into hardware - Bloomberg
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- SEC accuses ex-BofA senior banker Satsky of insider trading - Bloomberg
Create E-mail Alert Related Categories
FDA, Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
